Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls.
Anticancer Res. 2003 Mar-Apr;23(2A):851-3.
Anticancer Res. 2003.
PMID: 12820312
Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening.
Hardt PD, Toepler M, Ngoumou B, Rupp J, Kloer HU.
Hardt PD, et al. Among authors: toepler m.
Anticancer Res. 2003 Mar-Apr;23(2A):855-7.
Anticancer Res. 2003.
PMID: 12820313
Item in Clipboard
Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer.
Hardt PD, Mazurek S, Toepler M, Schlierbach P, Bretzel RG, Eigenbrodt E, Kloer HU.
Hardt PD, et al. Among authors: toepler m.
Br J Cancer. 2004 Aug 31;91(5):980-4. doi: 10.1038/sj.bjc.6602033.
Br J Cancer. 2004.
PMID: 15266315
Free PMC article.
Item in Clipboard
[Pyruvate kinase M2 (tumor M2-PK) as a screening tool for colorectal cancer (CRC). A review of current published data].
Ewald N, Toepler M, Akinci A, Kloer HU, Bretzel RG, Hardt PD.
Ewald N, et al. Among authors: toepler m.
Z Gastroenterol. 2005 Dec;43(12):1313-7. doi: 10.1055/s-2005-858657.
Z Gastroenterol. 2005.
PMID: 16315127
Review.
German.
Item in Clipboard
Cite
Cite